Cristof Westenfelder
Algemeen Directeur bij SymbioCellTech LLC
Profiel
Cristof Westenfelder is the founder of SymbioCellTech LLC, founded in 2006, where he holds the title of Chief Executive Officer & Chairman.
He was also the founder of AlloCure, Inc., founded in 2008, where he held the title of Chief Medical Officer from 2008 to 2010.
Dr. Westenfelder's former job was as a Professor at the University of Utah.
Actieve functies van Cristof Westenfelder
| Bedrijven | Functie | Begin |
|---|---|---|
SymbioCellTech LLC
 SymbioCellTech LLC BiotechnologyHealth Technology SymbioCellTech LLC engages in biotechnology company. It develops treatment to reduce or elimininate the need for external insulin therapy in insulin-dependent diabetes. The company was founded by Christof Westenfelder and Axel Zander in 2006 and is headquartered in Salt Lake, UT. | Algemeen Directeur | 01-01-2006 |
Eerdere bekende functies van Cristof Westenfelder
| Bedrijven | Functie | Einde |
|---|---|---|
| University of Utah | Corporate Officer/Principal | - |
AlloCure, Inc.
 AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
AlloCure, Inc.
AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Health Technology |
SymbioCellTech LLC
SymbioCellTech LLC BiotechnologyHealth Technology SymbioCellTech LLC engages in biotechnology company. It develops treatment to reduce or elimininate the need for external insulin therapy in insulin-dependent diabetes. The company was founded by Christof Westenfelder and Axel Zander in 2006 and is headquartered in Salt Lake, UT. | Health Technology |
